Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-05-03, Stock:JNJ, The news for the past five days is as follows:
2021-04-26: NEWS1: Why BioNTech Fell by 7% Today Before Recovering.NEWS2: UPDATE 1-J&J execs get pay raises, but only after bruising shareholder 'Vote No' campaign.NEWS3: Biden will reportedly announce new CDC mask guidance Tuesday.NEWS4: J&J execs get pay raises, but only after bruising shareholder 'Vote No' campaign.NEWS5: Canada supports use of Johnson & Johnson's COVID-19 vaccine despite reports of rare blood clots.NEWS6: 3 Income Favorites Raising Dividends.NEWS7: UPDATE 2-Venezuela keen on J&J vaccine but seeks details on side effects, official says.NEWS8: Johnson & Johnson: A Huge Vaccine Upside.NEWS9: Biden administration to share access to U.S.’s pipeline of AstraZeneca vaccine to help close global gap.NEWS10: Biden administration to open U.S.’s pipeline of AstraZeneca vaccine to help close global gap.NEWS11: The Johnson & Johnson vaccine ‘has become critically important’: Doctor.NEWS12: Johnson & Johnson Vaccinations Resume Amid Declining U.S. Infections.NEWS13: Doctor on updated mask guidelines: 'I think the time is now'.NEWS14: Biden set to announce new CDC mask guidance Tuesday: RPT.NEWS15: Why There’s Room for More Players in the Covid-19 Vaccine Market.NEWS16: U.S. resumes J&J vaccine with warning.NEWS17: Johnson & Johnson Looks To Offload Breast Implant Business, Once Again: Bloomberg.NEWS18: France's Sanofi to help Moderna manufacture COVID-19 shots.NEWS19: UPDATE 1-South African study using J&J vaccine will resume on Wednesday.NEWS20: J&J vaccine study to resume in South Africa on Wednesday, ministry says.
2021-04-27: NEWS1: Bayou Intermediate II, LLC -- Moody's assigns a B2 CFR to Bayou Intermediate II, LLC; outlook stable.NEWS2: Top Pharma Giants Expected to Be Most Active in M&A.NEWS3: CDC’s latest guidance on outdoor mask wearing ‘is a big milestone’: Doctor.NEWS4: CDC: Small groups of people can gather outside without masks.NEWS5: India’s COVID surge is ‘beyond heartbreaking,’ says WHO director-general, as first relief supplies arrive.NEWS6: U.S. probing two new blood clot cases after J&J's COVID-19 vaccine.NEWS7: 3 Dividend Stocks That Just Hiked Their Payouts.NEWS8: This Pharma Giant Lost the Vaccine Race, But Its COVID-19 Journey May Not Be Over.NEWS9: Is There Any Hope Left for Emergent BioSolutions?.NEWS10: 3 Reasons Not to Buy Johnson & Johnson Stock Just Because Its COVID Vaccine Pause Was Lifted.NEWS11: Is There Any Hope for Inovio?.NEWS12: California man hospitalized with blood clot after J&J vaccination.
2021-04-28: NEWS1: Streaming TV, Burritos, Beer, and Capital Gains Taxes.NEWS2: Starbucks CEO: Vaccines and the 'great human reconnection' create a 2- to 3-year tailwind.NEWS3: It’s ‘good to lift’ COVID-19 restrictions right now: UAB Epidemiologist .NEWS4: 3 Top Healthcare Stocks to Buy and Hold for the Next 10 Years.NEWS5: Strong New Drugs Sales to Aid AbbVie's (ABBV) Q1 Earnings.NEWS6: Vaccinated Americans 'can now enjoy some more freedoms,' health expert explains.
2021-04-29: NEWS1: UPDATE 2-Emergent hopes to answer U.S. FDA on Baltimore plant within days.NEWS2: Dr. Krutika Kuppalli explains why COVID-19 cases could get worse in India before improving.NEWS3: Moderna ramps up investments to triple vaccine output, eyes boosters.NEWS4: NYC reopening timeline is a ‘disastrous issue’: Doctor.NEWS5: Doctor: Travel ban from India to the U.S. could be 'counterproductive'.NEWS6: 7 Reasons to Invest in Dividend-Paying Stocks for Retirement.NEWS7: Better Buy: Johnson & Johnson Stock or the Entire S&P 500?.NEWS8: Is Novavax Stock A Buy On Hints Its Covid Vaccine Is Nearing Authorization?.NEWS9: Spain's Reig Jofre new plant to produce J&J vaccine by end-Q2.
2021-04-30: NEWS1: 'Things are going to get much worse before they get better' in India: Expert.NEWS2: West Virginia Governor on offering incentives after state ‘hit a wall’ in vaccinations.NEWS3: Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: Bloomberg.NEWS4: West Virginia city takes big three drug distributors to court over opioids.NEWS5: California has lowest COVID-19 case rate in the U.S.: RPT.NEWS6: Pharma Stock Roundup: Big Drugmakers' Q1 Earnings, Resumption of JNJ US COVID-19 Jabs.NEWS7: Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days.NEWS8: South Africa regulator says J&J shot can be given to pregnant women.NEWS9: Emergent (EBS) Beats on Q1 Earnings, Cuts Contract Revenue View.

Answer: Rise